Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

por Camilleri, Eleonora, van Rein, Nienke, van der Meer, Felix J. M., Nierman, Melchior C., Lijfering, Willem M., Cannegieter, Suzanne C.
Publicado 2021

Effect of multidose drug dispensing on the time in therapeutic range in patients using vitamin‐K antagonists: A randomized controlled trial

por Mertens, Bram J., Kwint, Henk‐Frans, Belitser, Svetlana V., van der Meer, Felix J. M., van Marum, Rob J., Bouvy, Marcel L.
Publicado 2019

Selective Serotonin Reuptake Inhibitor Use and Risk of Major Bleeding during Treatment with Vitamin K Antagonists: Results of A Cohort Study

por Bakker, Sanne, Burggraaf, Johanna Louise I., Kruip, Marieke J. H. A., van der Meer, Felix J. M., Lijfering, Willem M., van Rein, Nienke
Publicado 2022

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists

por van Rein, Nienke, Lijfering, Willem M., Bos, Mettine H. A., Herruer, Martien H., Vermaas, Helga W., van der Meer, Felix J. M., Reitsma, Pieter H.
Publicado 2016

Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists

por van Heteren, D. Max, Lijfering, Willem M., van der Meer, Felix J. M., Reitsma, Pieter H., Swen, Jesse J., Bos, Mettine H. A., van Rein, Nienke
Publicado 2022

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

por Toorop, Myrthe M. A., van Rein, Nienke, Nierman, Melchior C., Vermaas, Helga W., Huisman, Menno V., van der Meer, Felix J. M., Cannegieter, Suzanne C., Lijfering, Willem M.
Publicado 2020

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns

por Toorop, Myrthe M. A., van Rein, Nienke, Nierman, Melchior C., Vermaas, Helga W., Huisman, Menno V., van der Meer, Felix J. M., Cannegieter, Suzanne C., Lijfering, Willem M.
Publicado 2020

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

por Toorop, Myrthe M. A., van Rein, Nienke, Nierman, Melchior C., Vermaas, Helga W., Huisman, Menno V., van der Meer, Felix J. M., Cannegieter, Suzanne C., Lijfering, Willem M.
Publicado 2021

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

por Zielinski, Gilda Denise, van Rein, Nienke, Teichert, Martina, Klok, Frederikus A., Rosendaal, Frits R., van der Meer, Felix J. M., Huisman, Menno V., Cannegieter, Suzanne C., Lijfering, Willem M.
Publicado 2019

Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

por Zielinski, Gilda D., van Rein, Nienke, Teichert, Martina, Klok, Frederikus A., Rosendaal, Frits R., van der Meer, Felix J. M., Huisman, Menno V., Cannegieter, Suzanne C., Lijfering, Willem M.
Publicado 2021

Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

por Toorop, Myrthe M. A., Chen, Qingui, Kruip, Marieke J. H. A., van der Meer, Felix J. M., Nierman, Melchior C., Faber, Laura, Goede, Lies, Cannegieter, Suzanne C., Lijfering, Willem M.
Publicado 2021

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment

por Kooiman, Judith, van Hagen, Nadja, Iglesias del Sol, Antonio, Planken, Erwin V., Lip, Gregory Y. H., van der Meer, Felix J. M., Cannegieter, Suzanne C., Klok, Frederikus A., Huisman, Menno V.
Publicado 2015

The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists

por Visser, Chantal, Biedermann, Joseph S., Nierman, Melchior C., van der Meer, Felix J.M., Gulpen, Anouk J.W., Moors, Yvonne C.F., Cannegieter, Suzanne C., Lijfering, Willem M., Kruip, Marieke J.H.A.
Publicado 2022

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial

por Schol‐Gelok, Suzanne, de Maat, Moniek P. M., Biedermann, Joseph S., van Gelder, Teun, Leebeek, Frank W. G., Lijfering, Willem M., van der Meer, Felix J. M., Rijken, Dingeman C., Versmissen, Jorie, Kruip, Marieke J. H. A.
Publicado 2020

The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists

por Visser, Chantal, Biedermann, Joseph S., Nierman, Melchior C., Van der Meer, Felix J.M., Gulpen, Anouk J.W., Moors, Yvonne C.F., Cannegieter, Suzanne C., Lijfering, Willem M, Kruip, Marieke J.H.A., Dutch COVID & Thrombosis Coalition, The
Publicado 2021

Patients’ and health care providers’ perspectives on quality of hemophilia care in the Netherlands: a questionnaire and interview study

por Brands, Martijn R., Haverman, Lotte, Muis, Jelmer J., Driessens, Mariëtte H.E., van der Meer, Felix J.M., Goedhart, Geertje, Meijer, Stephan, de Jong, Marianne, van der Bom, Johanna G., Cnossen, Marjon H., Fijnvandraat, Karin, Gouw, Samantha C.
Publicado 2023

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

por Boon, Gudula J. A. M., van Rein, Nienke, Bogaard, Harm Jan, Ende-Verhaar, Yvonne M., Huisman, Menno V., Kroft, Lucia J. M., van der Meer, Felix J. M., Meijboom, Lilian J., Symersky, Petr, Vonk Noordegraaf, Anton, Klok, Frederikus A.
Publicado 2020

Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

por Boon, Gudula J. A. M., van Rein, Nienke, Bogaard, Harm Jan, Ende-Verhaar, Yvonne M., Huisman, Menno V., Kroft, Lucia J. M., van der Meer, Felix J. M., Meijboom, Lilian J., Symersky, Petr, Noordegraaf, Anton Vonk, Klok, Frederikus A.
Publicado 2020

Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients

por van Moort, Iris, Preijers, Tim, Hazendonk, Hendrika C.A.M., Schutgens, Roger E.G., Laros‐van Gorkom, Britta A.P., Nieuwenhuizen, Laurens, van der Meer, Felix J.M., Fijnvandraat, Karin, Leebeek, Frank W.G., Meijer, Karina, Mathôt, Ron A.A., Cnossen, Marjon H.
Publicado 2020

Validation of a perioperative population factor VIII pharmacokinetic model with a large cohort of pediatric hemophilia a patients

por Preijers, Tim, Liesner, Ri, Hazendonk, Hendrika C. A. M., Chowdary, Pratima, Driessens, Mariëtte H. E., Hart, Dan P., Laros‐van Gorkom, Britta A. P., van der Meer, Felix J. M., Meijer, Karina, Fijnvandraat, Karin, Leebeek, Frank W. G., Mathôt, Ron A. A., Cnossen, Marjon H.
Publicado 2021